Regional transcriptomic profiling reveals immune system enrichment in nonfailing atria as well as all chambers of the failing human heartShow others and affiliations
2023 (English)In: American Journal of Physiology. Heart and Circulatory Physiology, ISSN 0363-6135, E-ISSN 1522-1539, Vol. 325, no 6, p. H1430-H1445Article in journal (Refereed) Published
Abstract [en]
The different chambers of the human heart demonstrate regional physiological traits and may be differentially affected during pathologic remodeling, resulting in heart failure. Few previous studies have, however, characterized the different chambers at a transcriptomic level. We therefore conducted whole-tissue RNA sequencing and gene set enrichment analysis of biopsies collected from the four chambers of adult failing (n = 8) and nonfailing (n = 11) human hearts. Atria and ventricles demonstrated distinct transcriptional patterns. Compared to nonfailing ventricles, the transcriptional pattern of nonfailing atria was enriched for a large number of gene sets associated with cardiogenesis, the immune system and bone morphogenetic protein (BMP), transforming growth factor beta (TGF beta), MAPK/JNK and Wnt signaling. Differences between failing and nonfailing hearts were also determined. The transcriptional pattern of failing atria was distinct compared to that of nonfailing atria and enriched for gene sets associated with the innate and adaptive immune system, TGF beta/SMAD signaling, and changes in endothelial, smooth muscle cell and cardiomyocyte physiology. Failing ventricles were also enriched for gene sets associated with the immune system. Based on the transcriptomic patterns, upstream regulators associated with heart failure were identified. These included many immune response factors predicted to be similarly activated for all chambers of failing hearts. In summary, the heart chambers demonstrate distinct transcriptional patterns that differ between failing and nonfailing hearts. Immune system signaling may be a hallmark of all four heart chambers in failing hearts, and could constitute a novel therapeutic target.
Place, publisher, year, edition, pages
American Physiological Society, 2023. Vol. 325, no 6, p. H1430-H1445
Keywords [en]
Heart Failure, Immune system, Normal Heart, Transcriptomics, Upstream Regulators
National Category
Developmental Biology Genetics Medical Genetics Bioinformatics and Systems Biology Cell and Molecular Biology
Research subject
Bioinformatics
Identifiers
URN: urn:nbn:se:his:diva-23313DOI: 10.1152/ajpheart.00438.2023ISI: 001137584100002PubMedID: 37830984Scopus ID: 2-s2.0-85178497083OAI: oai:DiVA.org:his-23313DiVA, id: diva2:1805164
Funder
Swedish Heart Lung FoundationUniversity of SkövdeKnowledge FoundationSwedish Fund for Research Without Animal Experiments
Note
This study was funded by grants from the Swedish Society of Medicine, the Gothenburg Society of Medicine, the Heart-Lung Foundation, the Emelle Foundation, the foundations of the Sahlgrenska University Hospital, the University of Skövde, the Swedish Knowledge Foundation, the foundation Research Without Animal Experiments, and the Swedish Royal Academy and by ALF research grants from the Sahlgrenska University Hospital.
2023-10-162023-10-162024-05-20Bibliographically approved